Tissue factor and its natural inhibitor in pre-eclampsia and SGA (Q24323351)

Tissue factor pathway inhibitor

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Edi Vaisbuch

14

0 references

Tinnakorn Chaiworapongsa

8

Tinnakorn Chaiworapongsa

0 references

Francesca Gotsch

12

Francesca Gotsch

0 references

Juan Pedro Kusanovic

15

Juan Pedro Kusanovic

0 references

Shali Mazaki-Tovi

6

Shali Mazaki-Tovi

0 references

Offer Erez

1

Offer Erez

0 references

Roberto Romero

Roberto Romero

2

1 reference

ORCID Public Data File 2021

Jimmy Espinoza

7

Jimmy Espinoza

0 references

Nandor Gabor Than

4

Nandor Gabor Than

0 references

Debra Hoppensteadt

3

Debra Hoppensteadt

0 references

Jawed Fareed

5

Jawed Fareed

0 references

Lara A Friel

13

Lara Friel

0 references

Yoon Bo Hyun

10

Bo Hyun Yoon

0 references

author name string

Sung-Su Kim

9

0 references

Sonia S Hassan

Journal of Maternal-Fetal and Neonatal Medicine

11

0 references

language of work or name

English

0 references

publication date

December 2008

0 references

published in

0 references

volume

21

0 references

issue

12

0 references

page(s)

855-69

0 references

cites work

Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Soluble endoglin contributes to the pathogenesis of preeclampsia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Regulation of coagulation by a multivalent Kunitz-type inhibitor

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Fetal growth retardation and the arteries of the placental bed

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Exosomes: composition, biogenesis and function

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Inflammatory response in preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Microparticles and immunomodulation in pregnancy and pre-eclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The role of the immune system in preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Inflammation and pre-eclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Anti-inflammatory interventions in pregnancy: now and the future.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Fetal growth restriction: pathogenic mechanisms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

27 September 2017

Sources of tissue factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Recent advances in understanding of preeclampsia.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Latest advances in understanding preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Circulating angiogenic factors in preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Haemostasis in normal pregnancy: a balancing act?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The role of blood cells and their microparticles in blood coagulation.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Placental oxidative stress: from miscarriage to preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

New aspects in the pathophysiology of preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Cellular microparticles: new players in the field of vascular disease?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Th1/Th2 balance in preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Trophoblast deportation and the maternal inflammatory response in pre-eclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Quantification of heparin-induced TFPI release: a maximum release at low heparin dose

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The role of the coagulation system in tumour angiogenesis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The role of platelets in decrypting monocyte tissue factor

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The hemostatic system and angiogenesis in malignancy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Decidual cell-expressed tissue factor maintains hemostasis in human endometrium

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The pathogenesis of pre-eclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Physiological function of tissue factor pathway inhibitor and interaction with heparins

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The decidua regulates hemostasis in human endometrium

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Preeclampsia: an excessive maternal inflammatory response to pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Plasma interleukin-12 is elevated in patients with preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

A biological model for the regulation of peri-implantational hemostasis and menstruation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Is tissue factor pathway inhibitor involved in the antithrombotic effect of heparins? Biochemical considerations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Tissue factor pathway inhibitor and the revised theory of coagulation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Cellular interactions in tissue factor expression by blood monocytes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Placental protein 5: circulating levels in twin pregnancy and some observations on the analysis of biochemical data from multiple pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

On fibrinolysis and coagulation during parturition and menstruation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Enhanced thrombin generation in normal and hypertensive pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and tropho-blastic disease: Absence of PP5 expression in the malignant trophoblast

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Tissue factor in cancer angiogenesis and metastasis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Analysis of mononuclear cell subsets in pregnancies with intrauterine growth retardation. Evidence of chronic B-lymphocyte activation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Serum growth-promoting activity in human newborns. Relationship of thymidine activity with birth weight and the length of gestation

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Frequency of asymptomatic bacteriuria in preeclampsia

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Relative placental size in growth-retarded infants

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Bacteriuria due to ureaplasmas and other fastidious organisms during pregnancy: prevalence and significance.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Functional aspects of T-lymphocyte subsets in pregnancy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia

30 May 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Short- and long-term changes in plasma inflammatory markers associated with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Atherosis revisited: current concepts on the pathophysiology of implantation site disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Fetal growth restriction: a workshop report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Low urinary placental growth factor is a marker of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Risk factors for pre-eclampsia in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Leukocyte-platelet interaction in pregnancies complicated with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Urinary Placental Growth Factor and Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

21 January 2018

2 references

https://api.crossref.org/works/10.1080%2F14767050802361872

21 January 2018

12 December 2020

Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

Pharmacodynamic considerations in the selection of dosage of tinzaparin for various indications: experimental studies in primates.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Preeclampsia. A nested, case-control study of risk factors and their interactions.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171292

Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro

29 November 2018

1 reference

12 December 2020

Expression of tissue factor pathway inhibitor in human fetal and placental tissues

1 reference

12 December 2020

Neutrophil activation in preeclampsia and isolated intrauterine growth restriction

1 reference

12 December 2020

Angiogenesis and intrauterine growth restriction

1 reference

12 December 2020

Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism

1 reference

12 December 2020

Placental protein 5: disappearance from the circulation after delivery

1 reference

12 December 2020

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

12 December 2020

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

1 reference

12 December 2020

C5a induces tissue factor activity on endothelial cells

1 reference

12 December 2020

Mechanism of tissue factor activation on HL-60 cells

1 reference

12 December 2020

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

1 reference

12 December 2020

Tissue factor expression by monocytes: regulation and pathophysiological roles

1 reference

12 December 2020

Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia

1 reference

12 December 2020

Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia

1 reference

12 December 2020

Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation

1 reference

12 December 2020

Tissue factor activity in whole blood

1 reference

12 December 2020

The role of the anti-angiogenic factor endostatin in intrauterine growth restriction

1 reference

12 December 2020

Total and free tissue factor pathway inhibitor in pregnancy hypertension

1 reference

12 December 2020

Angiogenic factors and preeclampsia

1 reference

12 December 2020

Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key

1 reference

12 December 2020

Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles

1 reference

12 December 2020

Hypertensive disorders of pregnancy and the small for gestational age neonate: not a simple relationship

1 reference

12 December 2020

Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles

1 reference

12 December 2020

Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles

1 reference

12 December 2020

Oxidative stress alters the integrity of cell-free mRNA fragments associated with placenta-derived syncytiotrophoblast microparticles

1 reference

12 December 2020

Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction

1 reference

12 December 2020

Procoagulant activity of rabbit alveolar macrophages

1 reference

12 December 2020

Bacteriuria due to Ureaplasma urealyticum and Gardnerella vaginalis in women with preeclampsia

1 reference

12 December 2020

Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence

1 reference

12 December 2020

Dramatic increase of placental protein 5 levels following injection of small doses of heparin

1 reference

12 December 2020

Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia

1 reference

12 December 2020

On the pathogenesis of placental infarcts in pre-eclampsia

1 reference

12 December 2020

The Endotoxin-induced Coagulant Activity of Human Monocytes

1 reference

12 December 2020

The role of coagulation and fibrinolysis in preeclampsia

1 reference

12 December 2020

Specific interaction between placental protein 5 and heparin

1 reference

12 December 2020

An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation

1 reference

12 December 2020

Placental protein 5 (PP5) in pregnancy and malignant disease: the influence of heparin binding

1 reference

12 December 2020

Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin

1 reference

12 December 2020

Coagulation and fibrinolysis in preeclampsia and neonates

1 reference

12 December 2020

Induction of Intrauterine Growth Restriction by Reducing Placental Vascular Growth with the Angioinhibin TNP-470

1 reference

12 December 2020

Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia

1 reference

12 December 2020

Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss

1 reference

12 December 2020

Plasma markers of angiogenesis in pregnancy induced hypertension

1 reference

12 December 2020

An imbalance between vascular endothelial growth factor and its soluble receptor in placental villous explants of intrauterine growth-restricted pregnancies

1 reference

12 December 2020

Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation

1 reference

12 December 2020

Structure, function and biology of tissue factor pathway inhibitor-2

1 reference

12 December 2020

Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates

1 reference

12 December 2020

Obesity and preeclampsia: the potential role of inflammation

1 reference

12 December 2020

Activation of leukocytes during the uteroplacental passage in preeclampsia

1 reference

12 December 2020

1 reference

12 December 2020

Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia

1 reference

12 December 2020

Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients

1 reference

12 December 2020

Coagulation, fibrinolysis and angiogenesis: new insights from knockout mice

1 reference

12 December 2020

Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia

1 reference

12 December 2020

Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia

1 reference

12 December 2020

Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction

1 reference

12 December 2020

Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex-vivo thrombi

1 reference

12 December 2020

Circulating tissue factor, tissue factor pathway inhibitor and D-dimer in umbilical cord blood of normal term neonates and adult plasma

1 reference

12 December 2020

Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry

1 reference

12 December 2020

Neutrophil activation in small for gestational age pregnancies

1 reference

12 December 2020

Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation

1 reference

12 December 2020

Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count

1 reference

12 December 2020

Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia

1 reference

12 December 2020

Kinetics of factor Xa inhibition by tissue factor pathway inhibitor

1 reference

12 December 2020

Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin

1 reference

12 December 2020

Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome

1 reference

12 December 2020

Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide

1 reference

12 December 2020

Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin

1 reference

12 December 2020

Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent

1 reference

12 December 2020

Effect of repeated Aprosulate and Enoxaparin administration on tissue factor pathway inhibitor antigen levels

1 reference

12 December 2020

A United States national reference for fetal growth

1 reference

12 December 2020

Placental diagnostic criteria and clinical correlation – a workshop report

1 reference

12 December 2020

Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802361872

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1080/14767050802361872

0 references

Fatcat ID

release_h6kizy45ibg3bm75bxhb2uofti

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h6kizy45ibg3bm75bxhb2uofti

24 November 2022